TransMedics Group
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade TransMedics Group 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About TMDX
TransMedics Group, Inc. operates as a commercial stage medical technology company. The firm engages in the development and commercialization of organ care system platform.
CEOWaleed H. Hassanein
CEOWaleed H. Hassanein
Employees728
Employees728
HeadquartersAndover, Massachusetts
HeadquartersAndover, Massachusetts
Founded1998
Founded1998
Employees728
Employees728
TMDX Key Statistics
Market cap4.33B
Market cap4.33B
Price-Earnings ratio51.21
Price-Earnings ratio51.21
Dividend yield—
Dividend yield—
Average volume779.50K
Average volume779.50K
High today$128.81
High today$128.81
Low today$124.76
Low today$124.76
Open price$127.42
Open price$127.42
Volume553.31K
Volume553.31K
52 Week high$156.00
52 Week high$156.00
52 Week low$55.00
52 Week low$55.00
Stock Snapshot
TransMedics Group(TMDX) stock is priced at $124.76, giving the company a market capitalization of 4.33B. It carries a P/E multiple of 51.21.
On 2025-12-13, TransMedics Group(TMDX) stock traded between a low of $124.76 and a high of $128.81. Shares are currently priced at $124.76, which is 0.0% above the low and -3.1% below the high.
The TransMedics Group(TMDX)'s current trading volume is 553.31K, compared to an average daily volume of 779.5K.
During the past year, TransMedics Group(TMDX) stock moved between $55.00 at its lowest and $156.00 at its peak.
During the past year, TransMedics Group(TMDX) stock moved between $55.00 at its lowest and $156.00 at its peak.
Analyst ratings
77%
of 13 ratingsBuy
76.9%
Hold
23.1%
Sell
0%
People also own
Based on the portfolios of people who own TMDX. This list is generated using Robinhood data, and it’s not a recommendation.